Cancer Research Prevention Award Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montaner, S.
Right arrow Articles by Gutkind, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montaner, S.
Right arrow Articles by Gutkind, J. S.
[Cancer Research 61, 2641-2648, March 15, 2001]
© 2001 American Association for Cancer Research

Molecular Biology and Genetics

The Kaposi’s Sarcoma-associated Herpesvirus G Protein-coupled Receptor Promotes Endothelial Cell Survival through the Activation of Akt/Protein Kinase B1

Silvia Montaner, Akrit Sodhi, Salvatore Pece, Enrique A. Mesri and J. Silvio Gutkind2

Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4330 [S. M., A. S., S. P., J. S. G.]; NIH-Howard Hughes Medical Institute Research Scholars Program [A. S.]; Laboratory of Viral Oncogenesis, Division of Hematology-Oncology, Department of Medicine, Cornell University Medical College, New York, NY 10021 [E. A. M.]

The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor (KSHV-GPCR) is a key molecule in the pathogenesis of Kaposi’s sarcoma, playing a central role in the promotion of vascular endothelial growth factor (VEGF)-driven angiogenesis and spindle cell proliferation. We previously have shown that KSHV-GPCR has oncogenic potential when overexpressed in fibroblasts and is responsible for the expression and secretion of VEGF through the regulation of different intracellular signaling pathways (A. Sodhi et al., Cancer Res., 60: 4873–4880, 2000; C. Bais et al., Nature, 391: 86–89, 1998). Here, we describe that this constitutively active G protein-coupled receptor is able to promote cell survival in primary human umbilical vein endothelial cells and that this effect is independent of its ability to secrete VEGF because it is not prevented by the expression of antisense constructs for VEGF or the addition of VEGF-blocking antibodies. Instead we found that ectopic expression of KSHV-GPCR potently induces the kinase activity of Akt/protein kinase B in a dose-dependent manner and triggers its translocation to the plasma membrane. This signaling pathway requires the function of phosphatidylinositol 3'-kinase and is dependent on ß{gamma} subunits released from both pertussis toxin-sensitive and -insensitive G proteins. Furthermore, we found that KSHV-GPCR is able to protect human umbilical vein endothelial cells from the apoptosis induced by serum deprivation and that both wortmannin and the expression of a kinase-deficient Akt K179M mutant are able to block this effect. Finally, we observed that the AktK179M protein also inhibits the activation of nuclear factor-{kappa}B induced by KSHV-GPCR, suggesting that this transcription factor may represent one of the putative downstream targets for Akt in the survival-signaling pathway. These results provide further knowledge in the elucidation of the signal transduction pathways activated by KSHV-GPCR and support its key role in promoting the survival of viral-infected cells. Moreover, the present findings also emphasize the importance of this G protein-coupled receptor in the development of KSHV-related neoplasias.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J.-P. Couty, M. Lupu-Meiri, Y. Oron, and M. C. Gershengorn
Kaposi's Sarcoma-Associated Herpesvirus-G Protein-Coupled Receptor-Expressing Endothelial Cells Exhibit Reduced Migration and Stimulated Chemotaxis by Chemokine Inverse Agonists
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1142 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Chaisuparat, J. Hu, B. C. Jham, Z. A. Knight, K. M. Shokat, and S. Montaner
Dual Inhibition of PI3K{alpha} and mTOR as an Alternative Treatment for Kaposi's Sarcoma
Cancer Res., October 15, 2008; 68(20): 8361 - 8368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S.-J. Lee, S. Namkoong, Y.-M. Kim, C.-K. Kim, H. Lee, K.-S. Ha, H.-T. Chung, Y.-G. Kwon, and Y.-M. Kim
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2836 - H2846.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Rosenkilde, T. Benned-Jensen, H. Andersen, P. J. Holst, T. N. Kledal, H. R. Luttichau, J. K. Larsen, J. P. Christensen, and T. W. Schwartz
Molecular Pharmacological Phenotyping of EBI2: AN ORPHAN SEVEN-TRANSMEMBRANE RECEPTOR WITH CONSTITUTIVE ACTIVITY
J. Biol. Chem., May 12, 2006; 281(19): 13199 - 13208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. E. Brown, D. Fallin, I. Ruczinski, A. Hutchinson, B. Staats, F. Vitale, C. Lauria, D. Serraino, G. Rezza, G. Mbisa, et al.
Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Montaner, A. Sodhi, A. K. Ramsdell, D. Martin, J. Hu, E. T. Sawai, and J. S. Gutkind
The Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor as a Therapeutic Target for the Treatment of Kaposi's Sarcoma
Cancer Res., January 1, 2006; 66(1): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Cannon, E. Cesarman, and C. Boshoff
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2
Blood, January 1, 2006; 107(1): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Uddin, A. R. Hussain, K. A. Al-Hussein, P. S. Manogaran, A. Wickrema, M. I. Gutierrez, and K. G. Bhatia
Inhibition of Phosphatidylinositol 3'-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells
Clin. Cancer Res., April 15, 2005; 11(8): 3102 - 3108.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. K. Jensen, D. J. Manfra, M. G. Grisotto, A. P. Martin, G. Vassileva, K. Kelley, T. W. Schwartz, and S. A. Lira
The Human Herpes Virus 8-Encoded Chemokine Receptor Is Required for Angioproliferation in a Murine Model of Kaposi's Sarcoma
J. Immunol., March 15, 2005; 174(6): 3686 - 3694.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Masood, G. Xia, D. L. Smith, P. Scalia, J. G. Still, A. Tulpule, and P. S. Gill
Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium
Blood, February 1, 2005; 105(3): 1310 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. J. Paulsen, M. M. Rosenkilde, J. Eugen-Olsen, and T. N. Kledal
Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor
J. Virol., January 1, 2005; 79(1): 536 - 546.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Montaner, A. Sodhi, J.-M. Servitja, A. K. Ramsdell, A. Barac, E. T. Sawai, and J. S. Gutkind
The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia
Blood, November 1, 2004; 104(9): 2903 - 2911.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H.-G. Guo, S. Pati, M. Sadowska, M. Charurat, and M. Reitz
Tumorigenesis by Human Herpesvirus 8 vGPCR Is Accelerated by Human Immuodeficiency Virus Type 1 Tat
J. Virol., September 1, 2004; 78(17): 9336 - 9342.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. T. Krug, V. P. Pozharskaya, Y. Yu, N. Inoue, and M. K. Offermann
Inhibition of Infection and Replication of Human Herpesvirus 8 in Microvascular Endothelial Cells by Alpha Interferon and Phosphonoformic Acid
J. Virol., August 1, 2004; 78(15): 8359 - 8371.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Rosenkilde, K. A. McLean, P. J. Holst, and T. W. Schwartz
The CXC Chemokine Receptor Encoded by Herpesvirus saimiri, ECRF3, Shows Ligand-regulated Signaling through Gi, Gq, and G12/13 Proteins but Constitutive Signaling Only through Gi and G12/13 Proteins
J. Biol. Chem., July 30, 2004; 279(31): 32524 - 32533.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
E. W. Verschuren, N. Jones, and G. I. Evan
The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin
J. Gen. Virol., June 1, 2004; 85(6): 1347 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. M. Zhang, J. N. Rao, X. Guo, L. Liu, T. Zou, D. J. Turner, and J.-Y. Wang
Akt Kinase Activation Blocks Apoptosis in Intestinal Epithelial Cells by Inhibiting Caspase-3 after Polyamine Depletion
J. Biol. Chem., May 21, 2004; 279(21): 22539 - 22547.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Sodhi, S. Montaner, V. Patel, J. J. Gomez-Roman, Y. Li, E. A. Sausville, E. T. Sawai, and J. S. Gutkind
Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor
PNAS, April 6, 2004; 101(14): 4821 - 4826.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Verzijl, C. P. Fitzsimons, M. van Dijk, J. P. Stewart, H. Timmerman, M. J. Smit, and R. Leurs
Differential Activation of Murine Herpesvirus 68- and Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORF74 G Protein-Coupled Receptors by Human and Murine Chemokines
J. Virol., April 1, 2004; 78(7): 3343 - 3351.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Liu, G. Sandford, G. Fei, and J. Nicholas
G{alpha} Protein Selectivity Determinant Specified by a Viral Chemokine Receptor-Conserved Region in the C Tail of the Human Herpesvirus 8 G Protein-Coupled Receptor
J. Virol., March 1, 2004; 78(5): 2460 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. SODHI, S. MONTANER, and J. S. GUTKIND
Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
FASEB J, March 1, 2004; 18(3): 422 - 427.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. C. Tomlinson and B. Damania
The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Activates the Akt Signaling Pathway
J. Virol., February 15, 2004; 78(4): 1918 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
Y. Daaka
G Proteins in Cancer: The Prostate Cancer Paradigm
Sci. Signal., January 20, 2004; 2004(216): re2 - re2.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Dadke, B. H. Fryer, E. A. Golemis, and J. Field
Activation of p21-Activated Kinase 1-Nuclear Factor {kappa}B Signaling by Kaposi's Sarcoma-Associated Herpes Virus G Protein-Coupled Receptor during Cellular Transformation
Cancer Res., December 15, 2003; 63(24): 8837 - 8847.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. B. Kondapaka, S. S. Singh, G. P. Dasmahapatra, E. A. Sausville, and K. K. Roy
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
Mol. Cancer Ther., November 1, 2003; 2(11): 1093 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Yang, H. Zhang, T. Voyno-Yasenetskaya, and R. D. Ye
Requirement of G{beta}{gamma} and c-Src in D2 Dopamine Receptor-Mediated Nuclear Factor-{kappa}B Activation
Mol. Pharmacol., August 1, 2003; 64(2): 447 - 455.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac
Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. Watanabe, M. Sugaya, A. M. Atkins, E. A. Aquilino, A. Yang, D. L. Borris, J. Brady, and A. Blauvelt
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells
J. Virol., June 1, 2003; 77(11): 6188 - 6196.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Pati, J. S. Foulke Jr., O. Barabitskaya, J. Kim, B. C. Nair, D. Hone, J. Smart, R. A. Feldman, and M. Reitz
Human Herpesvirus 8-Encoded vGPCR Activates Nuclear Factor of Activated T Cells and Collaborates with Human Immunodeficiency Virus Type 1 Tat
J. Virol., May 15, 2003; 77(10): 5759 - 5773.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H.-G. Guo, M. Sadowska, W. Reid, E. Tschachler, G. Hayward, and M. Reitz
Kaposi's Sarcoma-Like Tumors in a Human Herpesvirus 8 ORF74 Transgenic Mouse
J. Virol., February 15, 2003; 77(4): 2631 - 2639.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. D. Estep, M. K. Axthelm, and S. W. Wong
A G Protein-Coupled Receptor Encoded by Rhesus Rhadinovirus Is Similar to ORF74 of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., February 1, 2003; 77(3): 1738 - 1746.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Cannon, N. J. Philpott, and E. Cesarman
The Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Has Broad Signaling Effects in Primary Effusion Lymphoma Cells
J. Virol., December 6, 2002; 77(1): 57 - 67.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. M. Ahola, N. Alkio, T. Manninen, and T. Ylikomi
Progestin and G Protein-Coupled Receptor 30 Inhibit Mitogen-Activated Protein Kinase Activity in MCF-7 Breast Cancer Cells
Endocrinology, December 1, 2002; 143(12): 4620 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. G. Polson, D. Wang, J. DeRisi, and D. Ganem
Modulation of Host Gene Expression by the Constitutively Active G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus
Cancer Res., August 1, 2002; 62(15): 4525 - 4530.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. C. Deregibus, V. Cantaluppi, S. Doublier, M. F. Brizzi, I. Deambrosis, A. Albini, and G. Camussi
HIV-1-Tat Protein Activates Phosphatidylinositol 3-Kinase/ AKT-dependent Survival Pathways in Kaposi's Sarcoma Cells
J. Biol. Chem., July 5, 2002; 277(28): 25195 - 25202.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. W. Otieno, C. Banura, E. Katongole-Mbidde, J. L. Johnson, M. Ghannoum, A. Dowlati, R. Renne, E. Arts, C. Whalen, M. M. Lederman, et al.
Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa
J Natl Cancer Inst, May 15, 2002; 94(10): 718 - 732.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Liu, M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary
The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the Ikappa B Kinase Complex
J. Biol. Chem., April 12, 2002; 277(16): 13745 - 13751.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. J. Smit, D. Verzijl, P. Casarosa, M. Navis, H. Timmerman, and R. Leurs
Kaposi's Sarcoma-Associated Herpesvirus-Encoded G Protein-Coupled Receptor ORF74 Constitutively Activates p44/p42 MAPK and Akt via Gi and Phospholipase C-Dependent Signaling Pathways
J. Virol., February 15, 2002; 76(4): 1744 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. K. Gruijthuijsen, P. Casarosa, S. J. F. Kaptein, J. L. V. Broers, R. Leurs, C. A. Bruggeman, M. J. Smit, and C. Vink
The Rat Cytomegalovirus R33-Encoded G Protein-Coupled Receptor Signals in a Constitutive Fashion
J. Virol., February 1, 2002; 76(3): 1328 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Masood, E. Cesarman, D. L. Smith, P. S. Gill, and O. Flore
Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor
Am. J. Pathol., January 1, 2002; 160(1): 23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. W. Shepard, M. Yang, P. Xie, D. D. Browning, T. Voyno-Yasenetskaya, T. Kozasa, and R. D. Ye
Constitutive Activation of NF-kappa B and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Galpha 13 and RhoA
J. Biol. Chem., November 30, 2001; 276(49): 45979 - 45987.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-P. Couty, E. Geras-Raaka, B. B. Weksler, and M. C. Gershengorn
Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Signals through Multiple Pathways in Endothelial Cells
J. Biol. Chem., August 31, 2001; 276(36): 33805 - 33811.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.